Abstract

ObjectivesBoth too little and too much sleep may be detrimental for health, and emerging evidence suggests links between diet and sleep duration. n-3 and n-6 fatty acids (FAs) have physiologic roles in sleep processes including initiation, regulation, and melatonin production. We aimed to assess the association of circulating n-3 and n-6 FA biomarkers with sleep duration in the Fatty Acids and Outcome Research Consortium (FORCE). MethodsA pooled cross-sectional analysis of harmonized individual-level analyses from 5 prospective cohorts was performed. FA biomarkers assessed included 18:3n-3, 20:5n-3, 22:5n-3, 22:6n-3, 18:2n-6, 20:4n-6, and the sum of n-3 FAs in lipid compartments (phospholipids, cholesterol esters, total plasma, and total serum). FAs were measured between 1993–2016 and expressed as % of total FAs. Sleep duration was self-reported and categorized as <7 hrs, 7–8 hrs or >8 hrs. The 5 pooled studies comprised 4,691 participants aged 35 to 96 from Finland, Iceland, Sweden and USA. Associations between FAs and sleep duration per interquintile range (10th-90thpercentile) were assessed with a standardized protocol including definitions for exposures, outcomes and covariates. Cohort level odds ratios (OR) were pooled with inverse-variance weighting. ResultsOverall, 1,229, 2,812 and 650 participants had sleep duration <7 hrs, 7–8 hrs (reference category) and >8 hrs, respectively. In pooled multivariable adjusted analyses, higher 22:6n-3 was associated with lower odds of sleeping >8 hrs (OR per interquintile range: 0.71, 95% CI: 0.53–0.94); as was the sum of n-3 FAs (OR per interquintile range: 0.76, 95% CI: 0.58–0.99). Other individual n-3 or n-6 FAs were not significantly associated with sleep duration >8 hrs; and none of the n-3 or n-6 FAs were associated with sleep duration <7 hrs. ConclusionsThese novel findings demonstrate relationships between n-3 FAs, especially 22:6n-3, and longer sleep duration. The results highlight the need for future prospective studies and interventions to establish temporality, causality, and potential mechanisms. Funding SourcesILSI North America.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.